Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 4:18 PM ISTNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Drug manufacturers to get deemed approval for license if authorities fail to reply in 7 working days Medical Dialogues Team18 Aug 2021 4:13 PM ISTNew Delhi: Through a recent Gazette notification, the Government has notified a draft amendment in the Drugs Rules, 1945, to add a provision for...
Torrent Pharma Tapentadol Nasal Spray gets CDSCO panel go ahead for phase 3 trial Medical Dialogues Team17 Aug 2021 3:40 PM ISTNew Delhi: The Ahmedabad-based pharmaceutical major, Torrent Pharma, has received permission from the Subject Expert Committee (SEC) of the Central...
Serum Institute acquires 50 percent stake of Schott Kaisha Medical Dialogues Team17 Aug 2021 12:30 PM ISTPune: With the aim of securing the supply of high-quality pharma packaging and becoming SCHOTT's joint venture partner, Serum Institute of India (SII)...
Drugs ceiling prices to be revised every 5 years: DoP amends DPCO 2013 Act Medical Dialogues Team16 Aug 2021 3:55 PM ISTNew Delhi: Through a recent gazette notification, Department of Pharmaceuticals (DoP), under the Ministry of Chemicals and Fertilizers, has decided...
Sun Pharma gets CDSCO panel nod to additional pack size of Gemcitabine Medical Dialogues Team16 Aug 2021 2:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Conduct phase 3 trial of Nafamostat Mesilatefor for marketing approval: CDSCO panel tells Cipla Medical Dialogues Team15 Aug 2021 11:30 AM ISTNew Delhi: Rejecting drug maker Cipla's proposal to market and manufacture Nafamostat Mesilate for injection at 50 mg/vial and 100mg/vial, the Subject...
Glenmark gets CDSCO panel nod for manufacturing, marketing Itraconazole Capsules Medical Dialogues Team15 Aug 2021 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark...
JnJ cancer drug Amivantamab gets CDSCO panel okay with waiver of local phase 3,4 trials Medical Dialogues Team14 Aug 2021 3:25 PM ISTNew Delhi: Considering an unmet medical need in the country, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
44 drug samples including Cipla Remdesivir fail to qualify CDSCO test, 1 declared misbranded Medical Dialogues Team14 Aug 2021 3:11 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 44...
Bharat Biotech study on Covaxin, nasal COVID jab cocktail gets DCGI nod: Report Medical Dialogues Team13 Aug 2021 3:49 PM ISTHyderabad: In a significant advancement in Covid 19 vaccine development, Bharat Biotech has got approval from the Drug Controller General of India...
Aurobindo Pharma to acquire 51 percent stake in veterinary pharma firm Cronus for Rs 420 crore Medical Dialogues Team13 Aug 2021 2:29 PM ISTNew Delhi: Aurobindo Pharma has announced a definitive agreement under which it would subscribe to new equity shares in Cronus Pharma Specialities...
